SAN FRANCISCO, Oct. 26, 2016 -- Zephyr Health, the leading Insights-as-a-Service solution provider to Life Sciences companies, today announced it was named as one of the Top 10 Fastest Growing Healthcare Solution Provider Companies by Insights Success for its innovative services and solutions. These include two new game-changing capabilities in Zephyr IlluminateTM – Referral Analytics and Segment Analytics – that revolutionize the way Life Sciences companies use global health data to engage with physicians, accounts, and institutions.
According to Insights Success, Zephyr Health “stays deeply engaged with the industry’s challenges and ahead of the opportunities to ensure that the insights they provide are answering the most pressing questions that their customers need to solve.”
“Having powerful analytical tools to bridge the gap between the abundance of disconnected data and insights-driven decision making is essential for Life Sciences companies to stay relevant in an industry as regulated and competitive as healthcare,” said William King, founder and executive chairman, Zephyr Health. “We are honored to be recognized for leadership in providing predictive insights to help Life Sciences companies make confident decisions faster with data-driven analytics.”
Zephyr Illuminate was cited as a vertical specialist among insights solutions providers in the May 2016 Forrester Research Report, Vendor Landscape: Insights Service Providers, PM360’s Most Innovative Start-ups, 2015, Insights Success’ 20 Most Valuable Enterprise Big Data Companies, 2015 and Gartner’s Cool Vendors in Life Sciences, 2015.
About Insights Success
Insights Success is a top global business magazine for enterprises focusing distinctively on emerging as well as leading fastest growing companies, their confrontational style of doing business and way of delivering effective and collaborative solutions to strengthen market share.
About Zephyr Health
Zephyr Health helps Life Sciences companies – pharmaceutical, biotech, medical device and diagnostics – engage the right physicians, accounts and institutions using insights from global health data. Zephyr Illuminate™ is a leading insights-as-a-service solution that integrates thousands of data sources to create precise and predictive insights. From pre-launch to product maturity, life sciences companies can make confident decisions faster with data-driven targeting and deep customer profiles. Zephyr Health's customers include Top 10 Pharmaceutical companies, Top 10 Biotech Companies and Top 10 Medical Device companies.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers and Icon Ventures. For more information, please visit: www.zephyrhealth.com.
Media Contact: Zephyr Health Global Communications [email protected]


Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 



